Many Different LINE-1 Retroelements Are Activated in Bladder Cancer.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
11 Dec 2020
Historique:
received: 27 10 2020
revised: 04 12 2020
accepted: 07 12 2020
entrez: 16 12 2020
pubmed: 17 12 2020
medline: 16 3 2021
Statut: epublish

Résumé

Human genomes contain about 100,000 LINE-1 (L1) retroelements, of which more than 100 are intact. L1s are normally tightly controlled by epigenetic mechanisms, which often fail in cancer. In bladder urothelial carcinoma (UC), particularly, L1s become DNA-hypomethylated, expressed and contribute to genomic instability and tumor growth. It is, however, unknown which individual L1s are activated. Following RNA-immunoprecipitation with a L1-specific antibody, third generation nanopore sequencing detected transcripts of 90 individual elements in the VM-Cub-1 UC line with high overall L1 expression. In total, 10 L1s accounted for >60% of the reads. Analysis of five specific L1s by RT-qPCR revealed generally increased expression in UC tissues and cell lines over normal controls, but variable expression among tumor cell lines from bladder, prostate and testicular cancer. Chromatin immunoprecipitation demonstrated active histone marks at L1 sequences with increased expression in VM-Cub-1, but not in a different UC cell line with low L1 expression. We conclude that many L1 elements are epigenetically activated in bladder cancer in a varied pattern. Our findings indicate that expression of individual L1s is highly heterogeneous between and among cancer types.

Identifiants

pubmed: 33322422
pii: ijms21249433
doi: 10.3390/ijms21249433
pmc: PMC7763009
pii:
doi:

Substances chimiques

Histones 0
Retroelements 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Oncotarget. 2014 Feb 15;5(3):853-9
pubmed: 24553397
Biochem Biophys Res Commun. 1996 May 15;222(2):460-5
pubmed: 8670227
Cell. 2008 Oct 3;135(1):23-35
pubmed: 18854152
Mob DNA. 2018 Jan 3;9:1
pubmed: 29308092
Nucleic Acids Res. 2013 Aug;41(15):7401-19
pubmed: 23749060
Methods Mol Biol. 2012;925:219-28
pubmed: 22907501
Nat Struct Mol Biol. 2020 Feb;27(2):179-191
pubmed: 32042152
Clin Epigenetics. 2015 Mar 01;7:17
pubmed: 25798207
Cell. 2013 Nov 21;155(5):1034-48
pubmed: 24267889
Nucleic Acids Res. 2005 Jan 1;33(Database issue):D498-500
pubmed: 15608246
Exp Cell Res. 2003 Jan 1;282(1):48-57
pubmed: 12490193
Front Biosci (Landmark Ed). 2018 Jan 1;23:1310-1319
pubmed: 28930601
Clin Chem. 2017 Apr;63(4):816-822
pubmed: 28188229
Nat Struct Mol Biol. 2020 Feb;27(2):168-178
pubmed: 32042151
Mol Cell. 2017 Nov 16;68(4):808-820.e5
pubmed: 29129640
Elife. 2016 Mar 26;5:
pubmed: 27016617
Genome Biol. 2009;10(9):R100
pubmed: 19772661
Nature. 2018 Jan 11;553(7687):228-232
pubmed: 29211708
BMC Bioinformatics. 2009 Feb 03;10:48
pubmed: 19192299
Mol Cell. 2019 Aug 8;75(3):590-604.e12
pubmed: 31230816
Front Microbiol. 2018 Sep 04;9:2088
pubmed: 30233553
World J Urol. 2007 Jun;25(3):297-302
pubmed: 17440731
Free Radic Biol Med. 2019 Apr;134:419-428
pubmed: 30703483
Sci Rep. 2020 Mar 2;10(1):3808
pubmed: 32123240
Clin Cancer Res. 2014 Apr 1;20(7):1978-89
pubmed: 24691641
Front Oncol. 2013 Sep 26;3:255
pubmed: 24133654
Nat Commun. 2019 Jul 18;10(1):3182
pubmed: 31320637
Biochem Pharmacol. 2006 Nov 30;72(11):1577-88
pubmed: 16854382
Biotechnol Lett. 2006 Oct;28(19):1601-13
pubmed: 16900335
Mol Cell Biol. 2007 Sep;27(18):6469-83
pubmed: 17562864
Bladder Cancer. 2016 Oct 27;2(4):449-463
pubmed: 28035326
Noncoding RNA. 2015 Dec 17;1(3):266-284
pubmed: 29861427
Nucleic Acids Res. 2010 Jan;38(Database issue):D613-9
pubmed: 19906737
Curr Cancer Drug Targets. 2015;15(3):227-42
pubmed: 25808076
PLoS Genet. 2015 Jul 02;11(7):e1005367
pubmed: 26134849
Epigenetics. 2017 Jun 3;12(6):465-475
pubmed: 28300471
Nat Genet. 2020 Mar;52(3):306-319
pubmed: 32024998
Nucleic Acids Res. 2010 Jul;38(12):3909-22
pubmed: 20215437
Am J Pathol. 2014 May;184(5):1280-6
pubmed: 24607009
Nucleic Acids Res. 2017 Mar 17;45(5):e31
pubmed: 27899577
Nat Rev Cancer. 2015 Jan;15(1):25-41
pubmed: 25533674
Science. 2014 Aug 01;345(6196):1251343
pubmed: 25082706
Nat Rev Cancer. 2017 Jul;17(7):415-424
pubmed: 28642606
Mol Cell. 2017 Oct 5;68(1):144-157.e5
pubmed: 28965817
Carcinogenesis. 2011 Oct;32(10):1484-92
pubmed: 21828060

Auteurs

Patcharawalai Whongsiri (P)

Department of Urology, Medical Faculty, Heinrich Heine University, 40225 Dusseldorf, Germany.

Wolfgang Goering (W)

Institute of Pathology, Medical Faculty, Heinrich Heine University, 40225 Dusseldorf, Germany.

Tobias Lautwein (T)

Biological and Medical Research Center (BMFZ), Heinrich Heine University, 40225 Dusseldorf, Germany.

Christiane Hader (C)

Department of Urology, Medical Faculty, Heinrich Heine University, 40225 Dusseldorf, Germany.

Günter Niegisch (G)

Department of Urology, Medical Faculty, Heinrich Heine University, 40225 Dusseldorf, Germany.

Karl Köhrer (K)

Biological and Medical Research Center (BMFZ), Heinrich Heine University, 40225 Dusseldorf, Germany.

Michèle J Hoffmann (MJ)

Department of Urology, Medical Faculty, Heinrich Heine University, 40225 Dusseldorf, Germany.

Wolfgang A Schulz (WA)

Department of Urology, Medical Faculty, Heinrich Heine University, 40225 Dusseldorf, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH